Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (91-100 of 350) with videos related to

Pageof 35
Sort By:
Important Advances in Oncology|January 1, 1988
Recent advances in the therapy of chronic myelogenous leukemiaM Talpaz, R Kurzrock, H M Kantarjian, et al.
Leukemia & Lymphoma|August 26, 1998
High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphomaL Fayad, F Cabanillas, M Talpaz, et al.
Leukemia|March 31, 1998
DNA in situ hybridization of individual colonies to determine lineage derivation in leukemiaR Kurzrock, M Talpaz, M Beran, et al.
The American Journal of Medicine|February 1, 1994
What is the contribution of molecular studies to the diagnosis of BCR-ABL-positive disease in adult acute leukemia?H Kantarjian, M Talpaz, E Estey, et al.
Lancet (London, England)|September 22, 1979
Absence of chromosomal changes in fetus after paternal chemotherapyA Shani, M Talpaz, J Chemke, et al.
Endocrine Reviews|August 1, 1991
LIF: not just a leukemia inhibitory factorR Kurzrock, Z Estrov, M Wetzler, et al.
Hematologic Pathology|January 1, 1988
Aberrant expression of the K-ras proto-oncogene in B-cell malignanciesJ Lee, M Talpaz, R Walters, et al.
Texas Medicine|April 1, 1989
Cardiac arrhythmia in a CML patient treated with interferonsK H Lee, J U Gutterman, M K Ali, et al.
Hematology/Oncology Clinics of North America|April 2, 1998
Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapyH M Kantarjian, F J Giles, S M O'Brien, et al.
Journal of Interferon Research|August 1, 1989
Phase I study of a combination of recombinant tumor necrosis factor-alpha and recombinant interferon-gamma in cancer patientsR Kurzrock, B Feinberg, M Talpaz, et al.
Pageof 35

Showing results (91-100 of 350) with videos related to

Sort By:
Pageof 35
Important Advances in Oncology|January 1, 1988
Recent advances in the therapy of chronic myelogenous leukemiaM Talpaz, R Kurzrock, H M Kantarjian, et al.
Leukemia & Lymphoma|August 26, 1998
High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphomaL Fayad, F Cabanillas, M Talpaz, et al.
Leukemia|March 31, 1998
DNA in situ hybridization of individual colonies to determine lineage derivation in leukemiaR Kurzrock, M Talpaz, M Beran, et al.
The American Journal of Medicine|February 1, 1994
What is the contribution of molecular studies to the diagnosis of BCR-ABL-positive disease in adult acute leukemia?H Kantarjian, M Talpaz, E Estey, et al.
Lancet (London, England)|September 22, 1979
Absence of chromosomal changes in fetus after paternal chemotherapyA Shani, M Talpaz, J Chemke, et al.
Endocrine Reviews|August 1, 1991
LIF: not just a leukemia inhibitory factorR Kurzrock, Z Estrov, M Wetzler, et al.
Hematologic Pathology|January 1, 1988
Aberrant expression of the K-ras proto-oncogene in B-cell malignanciesJ Lee, M Talpaz, R Walters, et al.
Texas Medicine|April 1, 1989
Cardiac arrhythmia in a CML patient treated with interferonsK H Lee, J U Gutterman, M K Ali, et al.
Hematology/Oncology Clinics of North America|April 2, 1998
Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapyH M Kantarjian, F J Giles, S M O'Brien, et al.
Journal of Interferon Research|August 1, 1989
Phase I study of a combination of recombinant tumor necrosis factor-alpha and recombinant interferon-gamma in cancer patientsR Kurzrock, B Feinberg, M Talpaz, et al.
Pageof 35